2018-2023 Global Paronychia Treatment Market Report (Status and Outlook)

August 2018 | 116 pages | ID: 2EDA84A57F3EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Paronychia Treatment market for 2018-2023.

Paronychia is a nail disease that is an often-tender bacterial or fungal infection of the hand or foot where the nail and skin meet at the side or the base of a finger or toenail. The infection can start suddenly (acute paronychia) or gradually (chronic paronychia).
When no pus is present, warm soaks for acute paronychia is reasonable, even though there is a lack of evidence to support its use. Antibiotics such as clindamycin or cephalexin are also often used, the first being more effective in areas where MRSA is common. If there are signs of an abscess (the presence of pus) drainage is recommended. Chronic paronychia is treated by avoiding whatever is causing it, a topical antifungal, and a topical steroid. In those who do not improve following these measures oral antifungals and steroids may be used or the nail fold may be removed surgically.
Over the next five years, LPI(LP Information) projects that Paronychia Treatment will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Paronychia Treatment market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• Acute Paronychia
• Chronic Paronychia
• Pyogenic Paronychia

Segmentation by application:

• Mupirocin Ointment
• Fusidic Acid Ointment
• Gentamicin Ointment
• Dicloxacillin

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• GlaxoSmithKline
• Glenmark Generics
• Teva Pharmaceutical Industries
• Eli Lilly
• Jonakayem Pharma Formulation
• Fougera Pharmaceuticals
• Taro Pharmaceutical Industries

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Paronychia Treatment market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Paronychia Treatment market by identifying its various subsegments.
• Focuses on the key global Paronychia Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Paronychia Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Paronychia Treatment submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Paronychia Treatment Market Size 2013-2023
  2.1.2 Paronychia Treatment Market Size CAGR by Region
2.2 Paronychia Treatment Segment by Type
  2.2.1 Acute Paronychia
  2.2.2 Chronic Paronychia
  2.2.3 Candidal Paronychia
  2.2.4 Pyogenic Paronychia
2.3 Paronychia Treatment Market Size by Type
  2.3.1 Global Paronychia Treatment Market Size Market Share by Type (2013-2018)
  2.3.2 Global Paronychia Treatment Market Size Growth Rate by Type (2013-2018)
2.4 Paronychia Treatment Segment by Application
  2.4.1 Mupirocin Ointment
  2.4.2 Fusidic Acid Ointment
  2.4.3 Gentamicin Ointment
  2.4.4 Dicloxacillin
2.5 Paronychia Treatment Market Size by Application
  2.5.1 Global Paronychia Treatment Market Size Market Share by Application (2013-2018)
  2.5.2 Global Paronychia Treatment Market Size Growth Rate by Application (2013-2018)

3 GLOBAL PARONYCHIA TREATMENT BY PLAYERS

3.1 Global Paronychia Treatment Market Size Market Share by Players
  3.1.1 Global Paronychia Treatment Market Size by Players (2016-2018)
  3.1.2 Global Paronychia Treatment Market Size Market Share by Players (2016-2018)
3.2 Global Paronychia Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PARONYCHIA TREATMENT BY REGIONS

4.1 Paronychia Treatment Market Size by Regions
4.2 Americas Paronychia Treatment Market Size Growth
4.3 APAC Paronychia Treatment Market Size Growth
4.4 Europe Paronychia Treatment Market Size Growth
4.5 Middle East & Africa Paronychia Treatment Market Size Growth

5 AMERICAS

5.1 Americas Paronychia Treatment Market Size by Countries
5.2 Americas Paronychia Treatment Market Size by Type
5.3 Americas Paronychia Treatment Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Paronychia Treatment Market Size by Countries
6.2 APAC Paronychia Treatment Market Size by Type
6.3 APAC Paronychia Treatment Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Paronychia Treatment by Countries
7.2 Europe Paronychia Treatment Market Size by Type
7.3 Europe Paronychia Treatment Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Paronychia Treatment by Countries
8.2 Middle East & Africa Paronychia Treatment Market Size by Type
8.3 Middle East & Africa Paronychia Treatment Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL PARONYCHIA TREATMENT MARKET FORECAST

10.1 Global Paronychia Treatment Market Size Forecast (2018-2023)
10.2 Global Paronychia Treatment Forecast by Regions
  10.2.1 Global Paronychia Treatment Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Paronychia Treatment Forecast by Type
10.8 Global Paronychia Treatment Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 GlaxoSmithKline
  11.1.1 Company Details
  11.1.2 Paronychia Treatment Product Offered
  11.1.3 GlaxoSmithKline Paronychia Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 GlaxoSmithKline News
11.2 Glenmark Generics
  11.2.1 Company Details
  11.2.2 Paronychia Treatment Product Offered
  11.2.3 Glenmark Generics Paronychia Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Glenmark Generics News
11.3 Teva Pharmaceutical Industries
  11.3.1 Company Details
  11.3.2 Paronychia Treatment Product Offered
  11.3.3 Teva Pharmaceutical Industries Paronychia Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Teva Pharmaceutical Industries News
11.4 Eli Lilly
  11.4.1 Company Details
  11.4.2 Paronychia Treatment Product Offered
  11.4.3 Eli Lilly Paronychia Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Eli Lilly News
11.5 Jonakayem Pharma Formulation
  11.5.1 Company Details
  11.5.2 Paronychia Treatment Product Offered
  11.5.3 Jonakayem Pharma Formulation Paronychia Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Jonakayem Pharma Formulation News
11.6 Fougera Pharmaceuticals
  11.6.1 Company Details
  11.6.2 Paronychia Treatment Product Offered
  11.6.3 Fougera Pharmaceuticals Paronychia Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Fougera Pharmaceuticals News
11.7 Taro Pharmaceutical Industries
  11.7.1 Company Details
  11.7.2 Paronychia Treatment Product Offered
  11.7.3 Taro Pharmaceutical Industries Paronychia Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 Taro Pharmaceutical Industries News

...

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Paronychia Treatment
Figure Paronychia Treatment Report Years Considered
Figure Market Research Methodology
Figure Global Paronychia Treatment Market Size Growth R